BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9577655)

  • 1. [The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and A beta 1-42 (43)].
    Younkin SG
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1099. PubMed ID: 9577655
    [No Abstract]   [Full Text] [Related]  

  • 2. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
    Scheuner D; Eckman C; Jensen M; Song X; Citron M; Suzuki N; Bird TD; Hardy J; Hutton M; Kukull W; Larson E; Levy-Lahad E; Viitanen M; Peskind E; Poorkaj P; Schellenberg G; Tanzi R; Wasco W; Lannfelt L; Selkoe D; Younkin S
    Nat Med; 1996 Aug; 2(8):864-70. PubMed ID: 8705854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Presenilin-1 (S182) causative gene of early-onset familial Alzheimer's disease].
    Ikeda M
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1441-7. PubMed ID: 8741394
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
    Tabira T
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New clues to Alzheimer's disease: unraveling the roles of amyloid and tau.
    Yankner BA
    Nat Med; 1996 Aug; 2(8):850-2. PubMed ID: 8705846
    [No Abstract]   [Full Text] [Related]  

  • 7. [From gene to disease; presenilins and Alzheimer disease].
    Roos RA; Cruts M
    Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2027-9. PubMed ID: 11695101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease due to presenilin mutations].
    Tabira T
    Nihon Rinsho; 2004 Jan; 62 Suppl():90-4. PubMed ID: 15011327
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.
    Murayama O; Tomita T; Nihonmatsu N; Murayama M; Sun X; Honda T; Iwatsubo T; Takashima A
    Neurosci Lett; 1999 Apr; 265(1):61-3. PubMed ID: 10327206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial Alzheimer's disease].
    Yanagisawa K
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):392-4. PubMed ID: 10434682
    [No Abstract]   [Full Text] [Related]  

  • 11. Presenilins and Alzheimer's disease: the role of A beta 42.
    Eckman CB
    J Neural Transm Suppl; 1998; 53():181-4. PubMed ID: 9700656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
    Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
    Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
    Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
    Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic factors in the pathogenesis of Alzheimer's disease: roles of beta-amyloid and presenilins].
    Iwatsubo T; Tomita T
    Tanpakushitsu Kakusan Koso; 1998 Oct; 43(13):1963-72. PubMed ID: 9789459
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics of Alzheimer's disease.
    Hutton M; Pérez-Tur J; Hardy J
    Essays Biochem; 1998; 33():117-31. PubMed ID: 10488446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: genotypes, phenotypes, and treatments.
    Selkoe DJ
    Science; 1997 Jan; 275(5300):630-1. PubMed ID: 9019820
    [No Abstract]   [Full Text] [Related]  

  • 18. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
    Walker ES; Martinez M; Brunkan AL; Goate A
    J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites.
    Sudoh S; Kawamura Y; Sato S; Wang R; Saido TC; Oyama F; Sakaki Y; Komano H; Yanagisawa K
    J Neurochem; 1998 Oct; 71(4):1535-43. PubMed ID: 9751187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
    Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
    Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.